Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Blood|March 15, 1995
Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell linesF Moreau-Gaudry, F Mazurier, M Bensidhoum, et al.
Annales De Biologie Clinique|January 28, 1999
[Prospects for gene therapy in hematology]F Moreau-Gaudry, F Mazurier, S Salesse, et al.
Blood|July 9, 1999
Correction of uroporphyrinogen decarboxylase deficiency (hepatoerythropoietic porphyria) in Epstein-Barr virus-transformed B-cell lines by retrovirus-mediated gene transfer: fluorescence-based selection of transduced cellsA Fontanellas, F Mazurier, F Moreau-Gaudry, et al.
The Journal of Gene Medicine|May 16, 2000
Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoterA Vekris, C Maurange, C Moonen, et al.
Journal of Inherited Metabolic Disease|June 1, 1997
Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyriaF Mazurier, F Moreau-Gaudry, S Salesse, et al.
Human Gene Therapy|January 1, 1995
Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transferF Moreau-Gaudry, C Ged, C Barbot, et al.
The Journal of Gene Medicine|March 30, 2000
Fluorescence-based selection of retrovirally transduced cells in congenital erythropoietic porphyria: direct selection based on the expression of the therapeutic geneA Fontanellas, F Mazurier, F Belloc, et al.
Oncogenesis|July 26, 2020
Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cellsM Caillot, J Bourgeais, H Dakik, et al.
BMC Medicine|March 26, 2010
The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-AS Dedieu, X Canron, H R Rezvani, et al.
Cancer Gene Therapy|January 23, 1999
Retroviral vector-mediated transfer of the interferon-alpha gene in chronic myeloid leukemia cellsS Salesse, F Moreau-Gaudry, V Pigeonnier-Lagarde, et al.
Pageof 2